Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for ...
Tag: Bristol-Myers Squibb Co
These are 3 big things we’re watching in the stock market this week
The stock market bounce last week showed once again just how dependent Wall Street has become on the whims of ...
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk, ...
Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam ...
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
Bristol Myers Squibb's Cobenfy drugCourtesy: Bristol Myers SquibbThe Food and Drug Administration on Thursday approved Bristol Myers Squibb's highly anticipated ...
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Kena Betancur | Corbis News | Getty ImagesPfizer had a "phenomenal" first quarter — and Wall Street took notice, CEO ...
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers ...
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January 25, ...
Biden administration’s Medicare drug price negotiations will face major tests in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) ...
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or ...
